title: Rituximab for follicular lymphoma: watch and wait, watch and worry, or watch and live?
authors.affiliation: Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: thomas.leblanc@duke.edu.
authors.forename: Thomas
authors.initials: T
authors.lastname: LeBlanc
authors.affiliation: Center for Learning Health Care, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
authors.forename: Arif
authors.initials: A
authors.lastname: Kamal
authors.affiliation: Center for Learning Health Care, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC, USA.
authors.forename: Amy
authors.initials: A
authors.lastname: Abernethy
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000188:drug therapy*; D008297:Male; D057832:Watchful Waiting
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents